Multi-ancestry population attributable risk assessment of common genetic variation in Alzheimer’s and Parkinson’s diseases
View ORCID ProfileLietsel Jones, Catalina Cerquera-Cleves, View ORCID ProfileArtur FS Schuh, Mary B Makarious, Hirotaka Iwaki, Mike A. Nalls, Alastair J Noyce, Global Parkinson’s Genetics Program (GP2), Cornelis Blauwendraat, Andrew Singleton, View ORCID ProfileIgnacio Mata, Sara Bandres-Ciga
doi: https://doi.org/10.1101/2024.09.23.24314240
Lietsel Jones
1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
2DataTecnica LLC, Washington DC, USA
Catalina Cerquera-Cleves
3Department of Neurosciences, Neurology Unit, Hospital Universitario San Ignacio, Bogotá, Colombia
4CHU de Québec Research Center, Axe Neurosciences, Université Laval, Quebec City, Canada
Artur FS Schuh
5Departamento de Farmacologia, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
6Serviço de Neurologia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil
Mary B Makarious
1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
2DataTecnica LLC, Washington DC, USA
Hirotaka Iwaki
1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
2DataTecnica LLC, Washington DC, USA
Mike A. Nalls
1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
2DataTecnica LLC, Washington DC, USA
Alastair J Noyce
7Centre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, UK
Cornelis Blauwendraat
1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
8Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA
Andrew Singleton
1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
8Laboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA
Ignacio Mata
9Genomic Medicine, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, United States
Sara Bandres-Ciga
1Center for Alzheimer’s and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
Data Availability
This project was supported by the Global Parkinson's Genetics Program (GP2). Data (DOI 10.5281/zenodo.13755496, release 8) used in the preparation of this article were obtained from GP2. GP2 is funded by the Aligning Science Across Parkinson's (ASAP) initiative and implemented by The Michael J. Fox Foundation for Parkinson's Research (https://gp2.org). For a complete list of GP2 members see https://gp2.org. All scripts for analyses are publicly available on GitHub (DOI 10.5281/zenodo.13774456; https://github.com/GP2code/PAR-ADPD/).
Posted September 24, 2024.
Multi-ancestry population attributable risk assessment of common genetic variation in Alzheimer’s and Parkinson’s diseases
Lietsel Jones, Catalina Cerquera-Cleves, Artur FS Schuh, Mary B Makarious, Hirotaka Iwaki, Mike A. Nalls, Alastair J Noyce, Global Parkinson’s Genetics Program (GP2), Cornelis Blauwendraat, Andrew Singleton, Ignacio Mata, Sara Bandres-Ciga
medRxiv 2024.09.23.24314240; doi: https://doi.org/10.1101/2024.09.23.24314240
Multi-ancestry population attributable risk assessment of common genetic variation in Alzheimer’s and Parkinson’s diseases
Lietsel Jones, Catalina Cerquera-Cleves, Artur FS Schuh, Mary B Makarious, Hirotaka Iwaki, Mike A. Nalls, Alastair J Noyce, Global Parkinson’s Genetics Program (GP2), Cornelis Blauwendraat, Andrew Singleton, Ignacio Mata, Sara Bandres-Ciga
medRxiv 2024.09.23.24314240; doi: https://doi.org/10.1101/2024.09.23.24314240
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (195)
- Cardiovascular Medicine (2873)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12596)
- Forensic Medicine (10)
- Gastroenterology (809)
- Genetic and Genomic Medicine (4470)
- Geriatric Medicine (405)
- Health Economics (717)
- Health Informatics (2865)
- Health Policy (1054)
- Hematology (378)
- HIV/AIDS (905)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4225)
- Nursing (226)
- Nutrition (619)
- Oncology (2215)
- Ophthalmology (628)
- Orthopedics (255)
- Otolaryngology (321)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1179)
- Primary Care Research (485)
- Public and Global Health (6810)
- Radiology and Imaging (1499)
- Respiratory Medicine (904)
- Rheumatology (430)
- Sports Medicine (371)
- Surgery (474)
- Toxicology (59)
- Transplantation (204)
- Urology (175)